Elodie Montaudon

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Computed Tomography

Advanced Non Small Cell Lung Cancer

Dna Methylation

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Didier Decaudin, Fariba Nemati, Julien Masliah Planchon, Agathe Seguin-Givelet, Marine Lefevre, Vesnie Etienne, Harry Ahnine, Quentin Peretti, Laura Sourd, Rania El-Botty, Lea Huguet, Sarah Lagha, Nadia Hegarat, Sergio Roman-Roman, Ivan Bièche, Nicolas Girard, Elodie Montaudon
Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients. Cancers 16 (16) (2024)
Didier Decaudin, Fariba Nemati, Julien Masliah Planchon, Agathe Seguin-Givelet, Marine Lefevre, Vesnie Etienne, Harry Ahnine, Quentin Peretti, Laura Sourd, Rania El-Botty, Lea Huguet, Sarah Lagha, Nadia Hegarat, Sergio Roman-Roman, Ivan Bièche, Nicolas Girard, Elodie Montaudon
Evaluation of Combined Chemotherapy and Genomic-Driven Targeted Therapy in Patient-Derived Xenografts Identifies New Therapeutic Approaches in Squamous Non-Small-Cell Lung Cancer Patients. Cancers 16 (16) (2024)
Mandy Lawson, Natalie Cureton, Susana Ros, Azadeh C Bashi, Jelena Urosevic, Sophie D'Arcy, Oona Delpuech, Michelle DuPont, David I Fisher, Eric T Gangl, Hilary J Lewis, Dawn Trueman, Neha Wali, Stuart Charles Williamson, Jennifer I Moss, Elodie Montaudon, Héloïse Derrien, Elisabetta Marangoni, Ricardo J Miragaia, Sladjana Gagrica, Pablo Morentin Gutierrez, Thomas Moss, Gareth A Maglennon, Daniel Sutton, Radoslaw Polanski, Alan Rosen, Jonathan Cairns, Pei Zhang, Mònica Sánchez-Guixé, Violeta Serra, Susan E Critchlow, James S Scott, Justin P O Lindemann, Simon T Barry, Teresa Klinowska, Christopher J Morrow, Larissa S Carnevalli
The next-generation oral selective estrogen receptor degrader camizestrant (AZD9833) suppresses ER+ breast cancer growth and overcomes endocrine and CDK4/6 inhibitor resistance. Cancer research (2023)